Quantessence Capital’s Globus Medical GMED Stock Holding History

Quantessence Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,223	Closed	-$700K	–	72
2025 Q3	$700K	Buy	+12,223	New	+$704K	0.22%	108

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quantessence Capital's GMED Position: Q4 2025 in Review

Quantessence Capital sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 12,223 shares — an estimated $700K sold.

Quantessence Capital first reported a position in GMED in Q3 2025 and held it in 1 quarter. The position peaked at $700K in Q3 2025. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

Quantessence Capital reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
Quantessence Capital sold 12,223 Globus Medical shares in Q4 2025, an estimated $700K.
Quantessence Capital first reported a position in Globus Medical in Q3 2025 and held it in 1 quarter.
Quantessence Capital's Globus Medical position peaked at $700K in Q3 2025.
561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Quantessence Capital's 13F filing for Q4 2025, filed 17 Feb 2026.